7 completed. 7 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Completed 7 |
| Phase 2 | 2 | Completed 2 |
Follow Drug Toxicity: new trials by email Literature Review of Drug Toxicity trials Research Report on Drug Toxicity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Protective Effect of Nicotinamide Riboside Against Acetaminophen Toxicity Acetaminophen and Nicotinamide Riboside, Acetaminophen - Drug Toxicity | Phase 1 | Completed | University of South Alabama | 26 | 2024-01-15 | 2026-04-06 |
| MW151-101: First-in-human Study of MW151 Placebo, MW151, 10mg, MW151, 20mg - Drug Toxicity | Phase 1 | Completed | Linda Van Eldik | 40 | 2019-10-22 | 2022-12-30 |
| Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment in Patients With Moderate to Severe Psoriasis Calcipotriol ointment, adipose-derived multipotent mesenchymal stem cells - Mesenchymal Stromal Cells, Psoriasis | Phase 1 / Phase 2 | Completed | Guangdong Provincial Hospital of Traditional Chinese Medicine | 8 | 2019-07-23 | 2023-08-24 |
| Safety and Efficacy of Expanded Allogeneic AD-MSCs in Patients With Moderate to Severe Psoriasis adipose-derived multipotent mesenchymal stem cells - Mesenchymal Stromal Cells, Psoriasis | Phase 1 / Phase 2 | Completed | Guangdong Provincial Hospital of Traditional Chinese Medicine | 7 | 2017-09-24 | 2023-08-25 |
| Phase I Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics of KD101 in Healthy Male Subjects KD101, placebo - Drug Toxicity | Phase 1 | Completed | Kwang Dong Pharmaceutical co., ltd. | 40 | 2013-12-01 | 2014-08-12 |
| Double-Blind Randomized Crossover Trial to Access Electrocardiogram Effects of HPN-100 HPN-100, HPN-100 or Placebo, Placebo - Drug Toxicity | Phase 1 | Completed | Amgen | 98 | 2010-05-01 | 2024-06-20 |
| Phase I Clinical Study of Soy Isoflavones in Healthy, Post-Menopausal Women High Dose Soy isoflavones - Drug Toxicity | Phase 1 | Completed | University of North Carolina | 36 | 2004-03-01 | 2007-06-26 |
Drug-Related Side Effects and Adverse Reactions (7) · Psoriasis (2) · Cognitive Dysfunction (1)
Chemically-Induced Disorders (7) · Skin Diseases (2) · Skin Diseases, Papulosquamous (2) · Skin and Connective Tissue Diseases (2) · Cognition Disorders (1) · Mental Disorders (1) · Neurocognitive Disorders (1)
2-(4-(4-methyl-6-phenylpyridazin-3-yl)piperazin-1-yl)pyrimidine (1) · Acetaminophen (1) · Moxifloxacin (1) · Niacinamide (1) · Soybean Proteins (1) · glycerol phenylbutyrate (1) · nicotinamide-beta-riboside (1)
Guangdong Provincial Hospital of Traditional Chinese Medicine (2) · Amgen (1) · Kwang Dong Pharmaceutical co., ltd. (1) · Linda Van Eldik (1) · University of North Carolina (1) · University of South Alabama (1)
United States (3) · China (2) · South Korea (1)
Chuanjian Lu (1) · Chuanjian Lu, PhD (1) · Howard Lee, Professor (1) · Linda J Van Eldik, PhD (1) · Steven H Zeisel, MD, PhD (1)
R01AG061898 (1)